Vanguard Global Advisers’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$311K Buy
64,274
+49,932
+348% +$207K ﹤0.01% 2306
2026
Q2
$58.9K Sell
14,342
-7,883
-35% -$36.8K ﹤0.01% 3012
2026
Q1
$101K Buy
+22,225
New +$76.9K ﹤0.01% 2722

Other funds holding IRD

Vanguard Global Advisers's IRD Position: Q3 2026 in Review

Vanguard Global Advisers increased its Opus Genetics (IRD) stake by 348% in Q3 2026, buying an estimated $207K and bringing the position to 64,274 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #2306.

Vanguard Global Advisers first reported a position in IRD in Q1 2026 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • Vanguard Global Advisers held 64,274 shares of Opus Genetics worth $311K as of Q3 2026.
  • Vanguard Global Advisers bought 49,932 Opus Genetics shares in Q3 2026, an estimated $207K.
  • Opus Genetics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2306 holding.
  • Vanguard Global Advisers first reported a position in Opus Genetics in Q1 2026 and has held it in 3 quarters since.
  • 114 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.